Cover Image
市場調查報告書

全球單核苷酸多型性(SNP:Single Nucleotide Polymorphism)基因型鑑定、分析市場預測

Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 308883
出版日期 內容資訊 英文 80 Pages
訂單完成後即時交付
價格
Back to Top
全球單核苷酸多型性(SNP:Single Nucleotide Polymorphism)基因型鑑定、分析市場預測 Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018
出版日期: 2014年07月23日 內容資訊: 英文 80 Pages
簡介

所謂單核苷酸多型性(SNP : Single Nucleotide Polymorphism)基因型鑑定(遺傳基因型判斷),是篩檢、分析各種基因內的SNP遺傳基因變異的手法。SNP通常存在於包含人類的所有物種。SNP的基因型鑑定及分析技術,可分析幾千種SNP,在全基因組基因型鑑定中也隱藏著潛力。從2013年到2018年,全球SNP基因型鑑定、分析市場預計以20.65%的年複合成長率推移。

本報告提供全球SNP(單核苷酸多型性)基因型鑑定、分析市場相關調查、全球市場的轉變與預測、各技術、用途、地區的趨勢、影響市場成長因素分析、競爭環境、主要經營者簡介等彙整。

第1章 摘要整理

第2章 簡稱

第3章 調查的對象

  • 市場概要
  • 提供產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場環境

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各技術市場

第8章 各用途市場

第9章 各地區市場

  • 南北美洲的SNP基因型鑑定、分析市場
    • 市場規模與預測
  • 歐洲、中東、非洲的SNP基因型鑑定、分析市場
    • 市場規模與預測
  • 亞太地區的SNP基因型鑑定、分析市場
    • 市場規模與預測

第10章 購買標準

第11章 市場促進因素

第12章 市場促進因素與其影響

第13章 市場上課題

第14章 市場促進因素及課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 供應商環境

  • 競爭模式
    • 主要消息
    • 收購、契約
  • 供應商分析
  • 其他的關注供應商

第18章 主要供應商分析

  • Affymetrix
  • F. Hoffmann La-Roche
  • Illumina
  • Thermo Fisher Scientific
    • 主要資料
    • 產業概要
    • 產業區分:各收益
    • 產品區隔:各收益
    • 銷售額:各地區
    • 產業策略
    • 主要資訊
    • SWOT分析

第19章 本系列的其他報告

圖表

目錄
Product Code: IRTNTR3889

About Single Nucleotide Polymorphism Genotyping and Analysis

Single Nucleotide Polymorphism (SNP) genotyping is the screening and analysis of genetic variations of SNPs in the genome of various species. SNPs are commonly present in all species including humans. SNP genotyping and analysis technology can analyze thousands of SNPs and has the potential for whole-genome genotyping. It is the most common genetic variation that occurs in the genetic makeup. It is an emerging field in life science, which provides an in-depth analysis of SNPs. It is generally used by researchers for genomics study. It has a broad range of applications in several industries such as Pharmaceuticals and Pharmacogenomics, Diagnostics Research, Agriculture Biotechnology, and Breeding and Animal Livestock. There are several technologies which are used for SNP genotyping and analysis such as SNP GeneChips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex, and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight.

TechNavio's analysts forecast the Global SNP Genotyping and Analysis market to grow at a CAGR of 20.65 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global SNP Genotyping and Analysis market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of SNP analysis systems, consumables, and services used in SNP analysis. In addition, predominant technologies used for SNP genotyping and analysis, such as SNP gene chips and microarrays, TaqMan allelic discrimination, SNP by pyrosequencing, SNPlex and MassARRAY Matrix-assisted Laser Desorption/Ionization-Time-of-Flight, are considered in the scope of the report.

TechNavio's report, the Global SNP Genotyping and Analysis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global SNP Genotyping and Analysis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Affymetrix Inc.
  • Illumina Inc.
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.

Other Prominent Vendors

  • Agilent Technologies Inc.
  • Douglas Scientific Llc.
  • Fluidigm Corp.
  • Luminex Corp.
  • PREMIER Biosoft Intl.
  • Promega Corp.
  • Qiagen N. V.
  • Sequenom Inc.
  • WaferGen Biosystems Inc.

Market Driver

  • Advances in Technology

For a full, detailed list, view our report.

Market Challenge

  • Reimbursement Complications

For a full, detailed list, view our report.

Market Trend

  • Increasing Pharmacogenomics Study

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Technology

08. Market Segmentation by Application

09. Geographical Segmentation

  • 09.1. SNP Genotyping and Analysis Market in the Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. SNP Genotyping and Analysis Market in the EMEA Region
    • 09.2.1. Market Size and Forecast
  • 09.3. SNP Genotyping and Analysis Market in the APAC region
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Acquisitions and Agreements
  • 17.2. Vendor Analysis
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Affymetrix
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Business Segmentation
    • 18.1.4. Business Segmentation by Revenue 2013
    • 18.1.5. Business Segmentation by Revenue 2012 and 2013
    • 18.1.6. Sales by Geography
    • 18.1.7. Business Strategy
    • 18.1.8. Key Information
    • 18.1.9. SWOT Analysis
    • 18.1.10. Strengths
    • 18.1.11. Weaknesses
    • 18.1.12. Opportunities
    • 18.1.13. Threats
  • 18.2. F. Hoffmann La-Roche
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Sales by Geography
    • 18.2.6. Business Strategy
    • 18.2.7. Key Information
    • 18.2.8. SWOT Analysis
    • 18.2.9. Strengths
    • 18.2.10. Weaknesses
    • 18.2.11. Opportunities
    • 18.2.12. Threats
  • 18.3. Illumina
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation
    • 18.3.4. Sales by Geography
    • 18.3.5. Business Strategy
    • 18.3.6. Key Information
    • 18.3.7. SWOT Analysis
    • 18.3.8. Strengths
    • 18.3.9. Weaknesses
    • 18.3.10. Opportunities
    • 18.3.11. Threats
  • 18.4. Thermo Fisher Scientific
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. Business Segmentation by Revenue
    • 18.4.4. Product Segmentation by Revenue
    • 18.4.5. Sales by Geography
    • 18.4.6. Business Strategy
    • 18.4.7. Key Information
    • 18.4.8. SWOT Analysis
    • 18.4.9. Strengths
    • 18.4.10. Weaknesses
    • 18.4.11. Opportunities
    • 18.4.12. Threats

19. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global SNP Genotyping and Analysis Market 2013-2018 (US$ million)
  • Exhibit 3: Global SNP Genotyping and Analysis Market Segmentation by Technology
  • Exhibit 4: Global SNP Genotyping and Analysis Market Segmentation by Application
  • Exhibit 5: Global SNP Genotyping and Analysis Market Segmentation by Application 2013
  • Exhibit 6: Global SNP Genotyping and Analysis Market by Geographical Segmentation 2013
  • Exhibit 7: SNP Genotyping and Analysis Market in the Americas 2013-2018 (US$ million)
  • Exhibit 8: SNP Genotyping and Analysis Market in the EMEA Region 2013-2018 (US$ million)
  • Exhibit 9: SNP Genotyping and Analysis Market in the APAC Region 2013-2018 (US$ million)
  • Exhibit 10: Global SNP Genotyping and Analysis Market by Geographical Segmentation 2013-2018 (US$ million)
  • Exhibit 11: Global SNP Genotyping and Analysis Market by Geographical Segmentation 2013-2018
  • Exhibit 12: Affymetrix: Business Segmentation 2013
  • Exhibit 13: Affymetrix: Business Segmentation by Revenue 2013
  • Exhibit 14: Affymetrix: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 15: Affymetrix: Sales by Geography 2013
  • Exhibit 16: F. Hoffmann-La Roche: Business Segmentation 2013
  • Exhibit 17: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 18: F. Hoffmann-La Roche: Sales by Geography 2013 (Pharmaceuticals Division)
  • Exhibit 19: F. Hoffmann-La Roche: Sales by Geography 2013 (Diagnostics Division)
  • Exhibit 20: Illumina: Business Segmentation 2013
  • Exhibit 21: Illumina: Sales by Geography 2013
  • Exhibit 22: Thermo Fisher Scientific: Business Segmentation by Revenue 2013
  • Exhibit 23: Thermo Fisher Scientific: Product Segmentation by Revenue 2013
  • Exhibit 24: Thermo Fisher Scientific: Sales by Geography 2013
Back to Top